DETERMINATION OF 4 METABOLITES OF THE PLASTICIZER DI(2-ETHYLHEXYL)PHTHALATE IN HUMAN URINE SAMPLES

Citation
Haam. Dirven et al., DETERMINATION OF 4 METABOLITES OF THE PLASTICIZER DI(2-ETHYLHEXYL)PHTHALATE IN HUMAN URINE SAMPLES, International archives of occupational and environmental health, 64(8), 1993, pp. 555-560
Citations number
20
Categorie Soggetti
Public, Environmental & Occupation Heath
ISSN journal
03400131
Volume
64
Issue
8
Year of publication
1993
Pages
555 - 560
Database
ISI
SICI code
0340-0131(1993)64:8<555:DO4MOT>2.0.ZU;2-7
Abstract
A method for biological monitoring of exposure to the plasticizer di(2 -ethylhexyl)phthalate (DEHP) is described. In this method the four mai n metabolites of DEHP [i.e., mono(2-ethylhexyl)phthalate (MEHP), mono( 5-carboxy-2-ethylpentyl)phthalate, mono(2-ethyl-5-oxohexyl)phthalate, and mono(2-ethyl-5-hydroxyhexyl)phthalate] are determined in urine sam ples. The procedure includes enzymatic hydrolysis, ether extraction, a nd derivatization with triethyloxonium tetrafluoroborate. Analysis is performed by gas chromatography-electron impact mass spectrometry. The detection limit for all four metabolites is less than 25 mug/l urine. The coefficient of variation based on duplicate determinations of uri ne samples of workers occupationally exposed to DEHP was 16% for MEHP (mean concentration 0.157 mg/l) and 6%-9% for the other three metaboli tes (mean concentrations 0.130-0.175 mg/l). The method described here was used to study DEHP metabolism in man. Most persons excrete mono(2- ethyl-5-oxohexyl)phthalate and mono(2-ethyl-5-hydroxyhexyl)phthalate a s a (glucuronide) conjugate. Mono(5-carboxy-2-ethylpentyl)phthalate is mainly excreted in free form, while for MEHP a large interindividual variation in conjugation status was observed. Of the four metabolites quantified, 52% are products of a (omega-1)-hydroxylation reaction of MEHP [i.e., mono(2-ethyl-5-oxohexyl)phthalate and mono(2-ethyl-5-hydro xyhexyl)phthalate], 22% is the product of a omega-hydroxylation reacti on of MEHP [i.e., mono(5-carboxy-2-ethylpentyl)phthalate], and 26% is not oxidized further (i.e., MEHP). A good correlation is obtained when the amount of MEHP (omega-hydroxylation products is compared with the amount of MEHP (omega-1)hydroxylation products in urine samples. When the internal dose of DEHP has to be established we recommend that the levels of all four metabolites of DEHP be studied in urine samples.